Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 17Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 13Colorectal Neoplasms 11Rectal Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Head and Neck Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Leukemia, Myeloid, Acute 8Colonic Neoplasms 8Kidney Neoplasms 7Congenital Abnormalities 7Carcinoma, Renal Cell 7Multiple Myeloma 6Lymphoma, Large B-Cell, Diffuse 6Gliosarcoma 6Glioblastoma 6Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Esophageal Neoplasms 5Central Nervous System Neoplasms 5Stomach Neoplasms 4Prostatic Neoplasms 4Precancerous Conditions 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4

Interventions

Docetaxel 5Gemcitabine 3Vinorelbine 2Erlotinib Hydrochloride 2Carboplatin 2surufatinib 1pemigatinib 1nimotuzumab 1lorlatinib 1Pemetrexed 1Paclitaxel 1Gene Expression Profiling 1Cisplatin 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Non-Small Cell Lung Cancer × Gene Expression Profiling × Clear all
NCT00161278 2008-07-30

Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling

University of Michigan Rogel Cancer Center

Phase 2 Terminated
1 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡